Human monoclonal antibody human cd134 (ox40) and methods of making and using same
AssigneeKyowa Kirin Co., Ltd.
InventorsShinichiro KATO, Rachel SOLOFF NUGENT, Hitoshi YOSHIDA, Michael CROFT
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Kirin Co., Ltd.
InventorsShinichiro KATO, Rachel SOLOFF NUGENT, Hitoshi YOSHIDA, Michael CROFT
Estimating the term…
The invention provides antibodies that specifically bind to OX40 (CD134), referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. Invention antibodies that specifically bind to OX40 include mammalian (human, primate, etc.), humanized and chimeric anti-OX40 antibodies. Invention antibodies and antibody subsequences (fragments) that specifically bind to OX40 include purified and isolated antibodies, as well as pharmaceutical formulations thereof, are useful in various methods including treatment, screening and detection methods.
An isolated or purified monoclonal antibody, or a fragment thereof, that specifically binds to an epitope in an amino acid sequence OX40 extracellular domain, wherein the antibody comprises:
Dependencies are inferred from the claim text.